Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$233.45 - $247.73 $340,370 - $361,190
-1,458 Reduced 4.07%
34,353 $8.5 Million
Q4 2023

Feb 02, 2024

BUY
$232.24 - $267.23 $94,289 - $108,495
406 Added 1.15%
35,811 $8.73 Million
Q3 2023

Nov 07, 2023

SELL
$254.9 - $283.59 $258,468 - $287,560
-1,014 Reduced 2.78%
35,405 $9.15 Million
Q2 2023

Jul 21, 2023

BUY
$238.39 - $265.32 $121,102 - $134,782
508 Added 1.41%
36,419 $9.62 Million
Q1 2023

May 04, 2023

SELL
$229.71 - $259.35 $191,348 - $216,038
-833 Reduced 2.27%
35,911 $8.89 Million
Q4 2022

Feb 07, 2023

BUY
$218.29 - $256.91 $433,305 - $509,966
1,985 Added 5.71%
36,744 $9.34 Million
Q3 2022

Oct 31, 2022

SELL
$51.03 - $264.23 $26,637 - $137,928
-522 Reduced 1.48%
34,759 $7.75 Million
Q2 2022

Jul 19, 2022

BUY
$234.74 - $275.42 $358,682 - $420,841
1,528 Added 4.53%
35,281 $8.7 Million
Q1 2022

Apr 21, 2022

BUY
$243.64 - $270.48 $282,866 - $314,027
1,161 Added 3.56%
33,753 $8.98 Million
Q4 2021

Jan 14, 2022

BUY
$230.08 - $250.94 $299,334 - $326,472
1,301 Added 4.16%
32,592 $8.2 Million
Q3 2021

Oct 07, 2021

BUY
$232.72 - $256.47 $530,368 - $584,495
2,279 Added 7.86%
31,291 $7.69 Million
Q2 2021

Jul 29, 2021

BUY
$232.65 - $254.58 $2.05 Million - $2.24 Million
8,797 Added 43.52%
29,012 $7.06 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $457,217 - $506,053
-1,970 Reduced 8.88%
20,215 $4.92 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $4.92 Million - $5.46 Million
22,185 New
22,185 $5.55 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track First Fiduciary Investment Counsel, Inc. Portfolio

Follow First Fiduciary Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Fiduciary Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Fiduciary Investment Counsel, Inc. with notifications on news.